ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis
NYSE:ARDT - US03980N1072 - Common Stock
12.53 USD
-0.16 (-1.26%)
12.65 USD
+0.12 (+0.96%)
ARDT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ARDT get a neutral evaluation. Nothing too spectacular is happening here. ARDT may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, ARDT could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year ARDT was profitable.
ARDT had a positive operating cash flow in the past year.
1.2 Ratios
With a decent Return On Assets value of 5.07%, ARDT is doing good in the industry, outperforming 78.22% of the companies in the same industry.
ARDT has a better Return On Equity (20.31%) than 88.12% of its industry peers.
ARDT's Return On Invested Capital of 8.74% is fine compared to the rest of the industry. ARDT outperforms 76.24% of its industry peers.
ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.14%.
The last Return On Invested Capital (8.74%) for ARDT is above the 3 year average (5.96%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.07% | ||
| ROE | 20.31% | ||
| ROIC | 8.74% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
ARDT has a better Profit Margin (4.11%) than 73.27% of its industry peers.
ARDT's Profit Margin has improved in the last couple of years.
The Operating Margin of ARDT (6.97%) is better than 70.30% of its industry peers.
In the last couple of years the Operating Margin of ARDT has grown nicely.
ARDT's Gross Margin of 57.76% is amongst the best of the industry. ARDT outperforms 80.20% of its industry peers.
ARDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.97% | ||
| PM (TTM) | 4.11% | ||
| GM | 57.76% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ARDT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ARDT has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ARDT has been reduced compared to a year ago.
2.2 Solvency
ARDT has an Altman-Z score of 2.17. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.17, ARDT perfoms like the industry average, outperforming 53.47% of the companies in the same industry.
The Debt to FCF ratio of ARDT is 10.26, which is on the high side as it means it would take ARDT, 10.26 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.26, ARDT perfoms like the industry average, outperforming 51.49% of the companies in the same industry.
ARDT has a Debt/Equity ratio of 0.87. This is a neutral value indicating ARDT is somewhat dependend on debt financing.
ARDT has a Debt to Equity ratio (0.87) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | 10.26 | ||
| Altman-Z | 2.17 |
ROIC/WACC1.07
WACC8.18%
2.3 Liquidity
A Current Ratio of 2.13 indicates that ARDT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.13, ARDT is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
A Quick Ratio of 2.00 indicates that ARDT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 2.00, ARDT is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
ARDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 314.38%, which is quite impressive.
Measured over the past years, ARDT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.75% on average per year.
Looking at the last year, ARDT shows a quite strong growth in Revenue. The Revenue has grown by 10.29% in the last year.
Measured over the past years, ARDT shows a small growth in Revenue. The Revenue has been growing by 7.00% on average per year.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%11.85%
3.2 Future
ARDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.38% yearly.
The Revenue is expected to grow by 6.58% on average over the next years.
EPS Next Y52.25%
EPS Next 2Y26.27%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue Next Year8.62%
Revenue Next 2Y6.8%
Revenue Next 3Y6.58%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.00 indicates a rather cheap valuation of ARDT.
98.02% of the companies in the same industry are more expensive than ARDT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ARDT to the average of the S&P500 Index (27.08), we can say ARDT is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.39, the valuation of ARDT can be described as very cheap.
98.02% of the companies in the same industry are more expensive than ARDT, based on the Price/Forward Earnings ratio.
ARDT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.67.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7 | ||
| Fwd PE | 6.39 |
4.2 Price Multiples
ARDT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ARDT is cheaper than 95.05% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ARDT is valued a bit cheaper than the industry average as 72.28% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.58 | ||
| EV/EBITDA | 4.06 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ARDT may justify a higher PE ratio.
A more expensive valuation may be justified as ARDT's earnings are expected to grow with 21.38% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y26.27%
EPS Next 3Y21.38%
5. Dividend
5.1 Amount
No dividends for ARDT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
12.53
-0.16 (-1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.34%
Inst Owner Change0.63%
Ins Owners1.98%
Ins Owner Change1.21%
Market Cap1.79B
Analysts81.18
Price Target20.09 (60.34%)
Short Float %1.88%
Short Ratio4.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.13%
Min EPS beat(2)43.05%
Max EPS beat(2)71.2%
EPS beat(4)3
Avg EPS beat(4)36.54%
Min EPS beat(4)-44.28%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.16%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)4.33%
Revenue beat(4)2
Avg Revenue beat(4)1.58%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.71%
PT rev (3m)-2.04%
EPS NQ rev (1m)-39.75%
EPS NQ rev (3m)-21.38%
EPS NY rev (1m)-4.12%
EPS NY rev (3m)-3.9%
Revenue NQ rev (1m)-4.58%
Revenue NQ rev (3m)-2.52%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7 | ||
| Fwd PE | 6.39 | ||
| P/S | 0.29 | ||
| P/FCF | 16.58 | ||
| P/OCF | 5.94 | ||
| P/B | 1.43 | ||
| P/tB | 5.98 | ||
| EV/EBITDA | 4.06 |
EPS(TTM)1.79
EY14.29%
EPS(NY)1.96
Fwd EY15.65%
FCF(TTM)0.76
FCFY6.03%
OCF(TTM)2.11
OCFY16.84%
SpS43.31
BVpS8.77
TBVpS2.1
PEG (NY)0.13
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.07% | ||
| ROE | 20.31% | ||
| ROCE | 10.43% | ||
| ROIC | 8.74% | ||
| ROICexc | 10.05% | ||
| ROICexgc | 13.67% | ||
| OM | 6.97% | ||
| PM (TTM) | 4.11% | ||
| GM | 57.76% | ||
| FCFM | 1.74% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | 10.26 | ||
| Debt/EBITDA | 1.87 | ||
| Cap/Depr | 129.12% | ||
| Cap/Sales | 3.13% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 51.85% | ||
| Profit Quality | 42.43% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2 | ||
| Altman-Z | 2.17 |
F-Score8
WACC8.18%
ROIC/WACC1.07
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%52.94%
EPS Next Y52.25%
EPS Next 2Y26.27%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%11.85%
Revenue Next Year8.62%
Revenue Next 2Y6.8%
Revenue Next 3Y6.58%
Revenue Next 5YN/A
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year69.06%
EBIT Next 3Y25.53%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A